
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1064 | 1040 | 1143 | 1331 | 1666 | 2708 |
Fund Return | 6.43% | 3.99% | 14.29% | 10.01% | 10.75% | 10.48% |
Place in category | 214 | 309 | 442 | 381 | 296 | 80 |
% in Category | 16 | 18 | 31 | 33 | 34 | 11 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Mellon Long Term Global Equity FuWG | 10.69M | 1.55 | 8.98 | 11.49 | ||
Mellon Long Term Global Equity FuWI | 3.6M | 1.55 | 8.98 | 11.49 | ||
Mellon Global Equity Income Fund SB | 1.11M | 6.33 | 9.20 | 9.66 | ||
Mellon Global Equity Income Fund SC | 1.18M | 6.42 | 9.77 | 10.21 | ||
Mellon Global Equity Income Fund St | 23.33M | 6.45 | 10.02 | 10.48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Guinness Global Equity Income Z | 6.61B | 3.98 | 11.53 | 11.54 | ||
Income Fund Sterling Accumulation | 3.89M | 6.79 | 8.96 | 9.81 | ||
Income Fund B Accumulation | 14.83M | 6.90 | 9.68 | 10.52 | ||
Income Fund B Income | 50.05M | 6.90 | 9.68 | 10.52 | ||
Income Fund Exempt 2 Income | 12.22M | 6.93 | 9.85 | 10.71 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
CME Group | US12572Q1058 | 3.39 | 253.78 | -0.27% | |
Sanofi | FR0000120578 | 3.07 | 91.41 | -4.78% | |
Medtronic | IE00BTN1Y115 | 2.50 | 82.87 | -0.02% | |
Cisco | US17275R1023 | 2.47 | 54.26 | -0.51% | |
AstraZeneca | GB0009895292 | 2.41 | 10,056.0 | -6.96% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review